Search Press releases Keywords From To 30 Nov 2021 UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases Read More 26 Nov 2021 Disposals of own shares Read More 19 Nov 2021 Disposals of own shares Read More 19 Nov 2021 Positive Top-Line Results from BIMZELX®▼(bimekizumab) Phase 3 Psoriatic Arthritis Study Demonstrated Significant Improvements in Joint and Skin Symptoms Read More 15 Nov 2021 Disposals of own shares Read More 5 Nov 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 44 Page 45 Page 46 Page 47 Current page 48 Page 49 Page 50 Page 51 Page 52 … Page 48 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
